Home / Companies / Caribou Biosciences, Inc. / 12 Jun 2025
Caribou Biosciences, Inc.: meeting of 12 Jun 2025
Votes reported on Form N-PX, item by item
66 Form N-PX filers reported votes at the Caribou Biosciences, Inc. meeting of 12 Jun 2025. Their records fall into 5 items below, in ballot order: management items first, then proposals from security holders. Each bar shows how the reporting filers split; it is not the result of the meeting.
foragainstabstain, withhold or otheramber tick: the portion cast against management
Items
DIRECTOR ELECTIONSIssuer
Director elections
2 nominees; 72.8% of reported votes for; 29 filers withheld from or voted against at least one nominee.
232 vote records from 65 filers. 5 of the 64 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
SECTION 14A SAY-ON-PAY VOTESIssuer
Advisory vote on executive pay (say-on-pay)
1 vote records from 1 filers. 0 of the 1 filers that marked the item either way voted against management.
AUDIT-RELATEDIssuer
Audit-related items (auditor ratification)
116 vote records from 65 filers. 1 of the 64 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CAPITAL STRUCTUREIssuer
CAPITAL STRUCTURE: management items
Management items in this category are shown together; filers word and number them differently.
114 vote records from 63 filers. 0 of the 62 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
CORPORATE GOVERNANCEIssuer
CORPORATE GOVERNANCE: management items
Management items in this category are shown together; filers word and number them differently.
115 vote records from 64 filers. 31 of the 63 filers that marked the item either way voted against management. 1 filer reported this item without a management mark.
How the largest families voted
| Family | 1. Directors | 3. Auditor |
|---|---|---|
| Vanguard | For | For |
| BlackRock and iShares | For | For |
| Fidelity | For | For |
| Dimensional | Abstain or withhold * | For |
| State Street and SPDR | For | For |
| Invesco | Split or no vote | For |
| Equitable | Abstain or withhold * | For |
| Charles Schwab | For | For |
| Nuveen and TIAA | For | For |
| ProShares and ProFunds | Split or no vote | For |
| John Hancock and Manulife | Split or no vote | For |
| Morgan Stanley, Eaton Vance and Calvert | Abstain or withhold * | For |
| Goldman Sachs | Split or no vote | For |
| WisdomTree | Split or no vote | For |
| PGIM and Prudential | Abstain or withhold * | For |
| Jackson National funds | Abstain or withhold * | For |
| Northern Trust and FlexShares | For | For |
| SEI | For | For |
| T. Rowe Price | For | For |
| Thrivent | Split or no vote | For |
| Lincoln Financial | For | For |
| Voya | Split or no vote | For |
| Russell Investments | For | For |
| Nationwide | For | For |
| Victory Capital | Split or no vote | For |
| Guggenheim and Rydex | Split or no vote | For |
| Columbia Threadneedle | For | For |
| Pacific Life funds | For | For |
| Global X | For | For |
| DWS | Split or no vote | For |
* against management. A family's position is the way most of its reported shares were voted across its filers; "split" means no single position led. "No report" means none of the family's filers listed the item.
Questions
How did large funds vote at the Caribou Biosciences, Inc. meeting?
66 Form N-PX filers reported votes at the meeting of 12 Jun 2025. On say-on-pay, 0 of 1 voted against management (0.0%). The family table lists each of the largest families item by item.
Is this the meeting result?
No. These are the votes of funds and managers that file Form N-PX, counted by filer and by the shares they reported. The certified result, which includes every shareholder, is reported by Caribou Biosciences, Inc. on Form 8-K.
Why are director elections shown as counts only?
Director records name the nominee. This site does not publish pages or rows about individuals, so for director elections it keeps the number of nominees and the split of votes and discards the wording.
Every meeting on file for Caribou Biosciences, Inc.
Provenance: SEC EDGAR, Form N-PX and N-PX/A filings listing Caribou Biosciences, Inc. with a meeting date within three days of 12 Jun 2025. Proposal titles are the most common wording among filers and are replaced by the SEC category where a wording could name a person. Not verified by the SEC. Filings read through 23 Sep 2026.